Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion type Assertion NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_head.
- NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion description "[In conclusion, our data are the first to show tumor-suppressive effects of miR-221 and miR-222 on lung cancer, warranting testing their potential as therapeutics for the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_provenance.
- NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion evidence source_evidence_literature NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_provenance.
- NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion SIO_000772 25641933 NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_provenance.
- NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion wasDerivedFrom befree-2016 NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_provenance.
- NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_assertion wasGeneratedBy ECO_0000203 NP1260163.RAPEb-FDO7ntW4JppLfgNed7bXK_gRZwbLsAeB1B6QcRI130_provenance.